journal article·2026-06-02Open access

ANKS1B in the Nucleus Accumbens Controls Escalated Cocaine Self‐Administration via Regulating CBP‐FoxO3 Complex

Liping Yang, Xiaoxuan Wu, Xuan Chen, Chao Peng, Zihang Li, Shumin Gao, Shiqiu Meng, Jing Dong, Dong Wu, Liying Lv, Ying Han, Yanxue Xue, Lin Lu, Jie Shi, Jianfeng Liu, Yan Sun

Abstract

ABSTRACT The transition from controlled to escalated drug intake is a core feature of cocaine use disorder (CUD), yet the molecular mechanisms underlying this behavioral escalation remain poorly defined. Our prior genome‐wide association study (GWAS) identified ANKS1B as a significant shared genetic risk factor for heroin, methamphetamine, and alcohol dependence, suggesting a broad role in addiction vulnerability. However, the specific function of ANKS1B in cocaine addiction and its associated neural mechanisms were unknown. Here, we found that ANKS1B expression level in the Nucleus Accumbens (NAc) was downregulated after extended cocaine use, and manipulating ANKS1B could selectively influence the escalation of cocaine intake and the subsequent cocaine‐seeking behavior in the long‐access cocaine self‐administration rat model. Molecular experiments reveal that ANKS1B interacts with the histone acetyltransferase CBP to control H3K27 acetylation and extended cocaine intake, via epigenetically repressing the transcription factor FoxO3. Overall, these findings suggest that ANKS1B is a crucial factor influencing the escalation of cocaine use. The ANKS1B‐CBP‐FoxO3 signaling pathway presents a promising target for potential therapeutic interventions for controlling extended cocaine use.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Neurotransmitter Receptor Influence on Behavior · FOXO transcription factor regulation · Genetic Associations and Epidemiology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Neurobiology School of Basic Medical Sciences National Institute on Drug Dependence Peking University Beijing China

Beijing Key Laboratory of Drug Dependence Research Peking University Beijing China

Peking University Sixth Hospital Peking University Institute of Mental Health Key of Mental Health Ministry of Health (Peking University) National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital) Beijing China

State Key Laboratory of Natural and Biomimetic Drugs Department of Molecular and Cellular Pharmacology School of Pharmaceutical Sciences Peking University Beijing China

Shandong Institute of Brain Science and Brain‐inspired Research Medical Science and Technology Innovation Center Shandong First Medical University & Shandong Academy of Medical Sciences Jinan China

College of Life Sciences and Health Wuhan University of Science and Technology Wuhan Hubei China

School of Basic Medical Sciences Zhengzhou University Zhengzhou China

Hospital of Tsinghua University (Beijing Huaxin Hospital) Beijing China

Peking‐Tsinghua Center for Life Sciences and PKU‐IDG/McGovern Institute for Brain Research Peking University Beijing China

Funding

National Natural Science Foundation of China

References (100+)

Show source-provided references
1. 10.1016/S0140‐6736(19)32230‐510.1016/S0140‐6736(19)32230‐5 ↗
2. 10.1016/j.drugalcdep.2017.08.03610.1016/j.drugalcdep.2017.08.036 ↗
3. 10.1007/s00213‐016‐4336‐410.1007/s00213‐016‐4336‐4 ↗
4. 10.1126/science.282.5387.29810.1126/science.282.5387.298 ↗
5. 10.1016/j.neuroscience.2011.08.01410.1016/j.neuroscience.2011.08.014 ↗
6. 10.1016/j.biopsych.2020.02.01710.1016/j.biopsych.2020.02.017 ↗
7. 10.1038/s41467‐019‐11437‐w10.1038/s41467‐019‐11437‐w ↗
8. 10.1523/jneurosci.4029‐14.201510.1523/jneurosci.4029‐14.2015 ↗
9. 10.3389/fnagi.2023.115256210.3389/fnagi.2023.1152562 ↗
10. 10.2217/pgs‐2019‐001510.2217/pgs‐2019‐0015 ↗
11. 10.1016/j.biopsych.2019.01.00610.1016/j.biopsych.2019.01.006 ↗
12. 10.1017/s003329172100174410.1017/s0033291721001744 ↗
13. 10.1186/s12920‐017‐0299‐510.1186/s12920‐017‐0299‐5 ↗
14. 10.1016/j.alcohol.2012.04.00410.1016/j.alcohol.2012.04.004 ↗
15. 10.1523/jneurosci.3254‐15.201610.1523/jneurosci.3254‐15.2016 ↗
16. 10.1002/ctm2.65910.1002/ctm2.659 ↗
17. 10.1038/s41380‐019‐0497‐y10.1038/s41380‐019‐0497‐y ↗
18. 10.1126/sciadv.170168210.1126/sciadv.1701682 ↗
19. 10.1016/j.neuron.2008.10.01210.1016/j.neuron.2008.10.012 ↗
20. 10.1523/jneurosci.2829‐20.202110.1523/jneurosci.2829‐20.2021 ↗
21. 10.1016/j.neuropharm.2014.01.04310.1016/j.neuropharm.2014.01.043 ↗
22. 10.1146/annurev.biochem.70.1.8110.1146/annurev.biochem.70.1.81 ↗
23. 10.1101/cshperspect.a03962810.1101/cshperspect.a039628 ↗
24. 10.1146/annurev‐psych‐122414‐03345710.1146/annurev‐psych‐122414‐033457 ↗
25. 10.1016/j.biopsych.2017.11.02710.1016/j.biopsych.2017.11.027 ↗
26. 10.1523/JNEUROSCI.3053‐14.201510.1523/JNEUROSCI.3053‐14.2015 ↗
27. 10.1111/j.1582‐4934.2009.00943.x10.1111/j.1582‐4934.2009.00943.x ↗
28. 10.1074/mcp.M400045‐MCP20010.1074/mcp.M400045‐MCP200 ↗
29. 10.1038/s41420‐025‐02519‐410.1038/s41420‐025‐02519‐4 ↗
30. 10.1111/bph.1506110.1111/bph.15061 ↗
31. 10.1038/s41598‐021‐82206‐310.1038/s41598‐021‐82206‐3 ↗
32. 10.7554/eLife.9042210.7554/eLife.90422 ↗
33. 10.1038/s41467‐024‐50099‐110.1038/s41467‐024‐50099‐1 ↗
34. 10.1111/bph.1582310.1111/bph.15823 ↗
35. 10.1016/j.biopsych.2014.02.00510.1016/j.biopsych.2014.02.005 ↗
36. 10.1016/j.biopsych.2005.04.04610.1016/j.biopsych.2005.04.046 ↗
37. 10.1016/j.neuron.2004.06.00210.1016/j.neuron.2004.06.002 ↗
38. 10.1016/j.celrep.2019.10.11610.1016/j.celrep.2019.10.116 ↗
39. 10.1038/s41598‐020‐62069‐w10.1038/s41598‐020‐62069‐w ↗
40. 10.1016/s0092‐8674(00)82001‐210.1016/s0092‐8674(00)82001‐2 ↗
41. 10.1038/nature0792510.1038/nature07925 ↗
42. 10.1016/j.jbc.2025.11071510.1016/j.jbc.2025.110715 ↗
43. 10.1073/pnas.151546511310.1073/pnas.1515465113 ↗
44. 10.3390/ijms23181079110.3390/ijms231810791 ↗
45. 10.1007/s12015‐023‐10575‐510.1007/s12015‐023‐10575‐5 ↗
46. 10.3390/epigenomes302001110.3390/epigenomes3020011 ↗
47. 10.3233/nha‐16000910.3233/nha‐160009 ↗
48. 10.1016/bs.ctdb.2017.10.00210.1016/bs.ctdb.2017.10.002 ↗
49. 10.1007/s11064‐021‐03364‐410.1007/s11064‐021‐03364‐4 ↗
50. 10.3390/ijms2510528710.3390/ijms25105287 ↗
51. 10.1038/s41388‐019‐1044‐710.1038/s41388‐019‐1044‐7 ↗
52. 10.1016/j.job.2025.10061410.1016/j.job.2025.100614 ↗
53. 10.1038/s41386‐018‐0054‐410.1038/s41386‐018‐0054‐4 ↗
54. 10.1038/npp.2017.10910.1038/npp.2017.109 ↗
55. 10.1523/jneurosci.2566‐07.200710.1523/jneurosci.2566‐07.2007 ↗
56. 10.3390/genes805013810.3390/genes8050138 ↗
57. 10.1016/j.isci.2021.10316910.1016/j.isci.2021.103169 ↗
58. 10.1016/j.neuropharm.2018.06.03610.1016/j.neuropharm.2018.06.036 ↗
59. 10.1111/adb.1272010.1111/adb.12720 ↗
60. 10.1186/s12993‐022‐00198‐010.1186/s12993‐022‐00198‐0 ↗
61. 10.1080/15592294.2017.128598610.1080/15592294.2017.1285986 ↗
62. 10.1016/j.nbd.2016.08.01410.1016/j.nbd.2016.08.014 ↗
63. 10.1038/npp.2015.15510.1038/npp.2015.155 ↗
64. 10.1016/j.conb.2007.04.00910.1016/j.conb.2007.04.009 ↗
65. 10.1126/science.118780110.1126/science.1187801 ↗
66. 10.2174/1570159×1766619061710172610.2174/1570159×17666190617101726 ↗
67. 10.1038/s41593‐023‐01436‐y10.1038/s41593‐023‐01436‐y ↗
68. 10.1038/s41380‐022‐01579‐710.1038/s41380‐022‐01579‐7 ↗
69. 10.1016/j.conb.2013.01.00110.1016/j.conb.2013.01.001 ↗
70. 10.1038/npp.2014.7010.1038/npp.2014.70 ↗
71. 10.1126/sciadv.aay035110.1126/sciadv.aay0351 ↗
72. 10.1038/nn87210.1038/nn872 ↗
73. 10.1016/j.biopha.2023.11595110.1016/j.biopha.2023.115951 ↗
74. 10.1523/jneurosci.0826‐15.201510.1523/jneurosci.0826‐15.2015 ↗
75. 10.1016/j.heliyon.2023.e1640710.1016/j.heliyon.2023.e16407 ↗
76. 10.1073/pnas.050973510210.1073/pnas.0509735102 ↗
77. 10.1523/jneurosci.2747‐11.201110.1523/jneurosci.2747‐11.2011 ↗
78. 10.1093/nar/gkq24410.1093/nar/gkq244 ↗
79. 10.1074/jbc.M40399720010.1074/jbc.M403997200 ↗
80. 10.1016/j.devcel.2014.11.03110.1016/j.devcel.2014.11.031 ↗
81. 10.1091/mbc.e05‐07‐061210.1091/mbc.e05‐07‐0612 ↗
82. 10.1073/pnas.060579410310.1073/pnas.0605794103 ↗
83. 10.1016/j.celrep.2016.11.01710.1016/j.celrep.2016.11.017 ↗
84. 10.2174/15672020778244630610.2174/156720207782446306 ↗
85. 10.1007/s00213‐022‐06097‐610.1007/s00213‐022‐06097‐6 ↗
86. 10.3390/biomedicines1105136810.3390/biomedicines11051368 ↗
87. 10.3389/fgene.2022.107615610.3389/fgene.2022.1076156 ↗
88. 10.1111/adb.1273610.1111/adb.12736 ↗
89. 10.1523/jneurosci.4012‐14.201510.1523/jneurosci.4012‐14.2015 ↗
90. 10.1016/j.tig.2017.10.00210.1016/j.tig.2017.10.002 ↗
91. 10.1016/j.celrep.2013.06.03510.1016/j.celrep.2013.06.035 ↗
92. 10.1126/science.121507010.1126/science.1215070 ↗
93. 10.1016/j.neuroscience.2009.01.06510.1016/j.neuroscience.2009.01.065 ↗
94. 10.1101/lm.029157.11210.1101/lm.029157.112 ↗
95. 10.1126/sciadv.adi446210.1126/sciadv.adi4462 ↗
96. 10.1016/j.bbi.2023.03.02710.1016/j.bbi.2023.03.027 ↗
97. 10.1038/s41380‐022‐01495‐w10.1038/s41380‐022‐01495‐w ↗
98. 10.3389/fnmol.2020.0000410.3389/fnmol.2020.00004 ↗
99. 10.1038/s41467‐024‐54430‐810.1038/s41467‐024‐54430‐8 ↗
100. 10.1016/0165‐0270(81)90045‐510.1016/0165‐0270(81)90045‐5 ↗